Aptevo Therapeutics APVO
NASDAQ APVO
$1.76 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Aptevo Therapeutics (APVO) Liabilities from Discontinued Operations (2021 - 2022)

Updated

Aptevo Therapeutics' Liabilities from Discontinued Operations was $23.34 million in Q1 2022, up 5.3% from $22.17 million a year earlier and up 49.8% from the prior quarter.

Analysis

Aptevo Therapeutics (APVO) Liabilities from Discontinued Operations (2021 - 2022) Analysis & Trends

At the end of FY2021, Liabilities from Discontinued Operations at Aptevo Therapeutics came in at $15.58 million.

  • Per Business Quant data, APVO's Liabilities from Discontinued Operations in the three quarters before Q1 2022 was $15.58 million (Q4 2021), $18.71 million (Q3 2021) and $20.54 million (Q2 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Aptevo Therapeutics 2.50 Mn -64.50 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 23.34 Mn
Dec 31, 2021 15.58 Mn
Sep 30, 2021 18.71 Mn
Jun 30, 2021 20.54 Mn
Mar 31, 2021 22.17 Mn
API Access

Aptevo Therapeutics Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=APVO&period=max&api_key=YOUR_API_KEY